Positions: Chair, Quantitative Health Sciences, Cleveland Clinic, 2004-present Professor of Medicine, Epidemiology and Biostatistics, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, 2006-present Education: PhD, Management Information Systems, University of Houston, 1993 Postdoc, Medical Informatics, Baylor College of Medicine, 1994 Honors/Service:: Journal of Clinical Oncology (Editorial Board, 2011 – Present) Personalized Medicine in Oncology (Editorial Board, 2011 – Present) European Urology (Editorial Board at Large, 2010 – Present) Clinical Genitourinary Cancer (Associate Editor, 2010 – Present) US Urology (Editorial Board, 2010 – Present) Annals of Urology (Editorial Board, 2010 – 2011) Cancer Investigation (Editorial Board, 2006 – Present) Nature Clinical Practice Urology (Advisory Board, 2005 – Present) Urologic Oncology: Seminars and Original Investigation (Associate Editor, 2003-Present) Medical Decision Making (Editorial Board, 1997-2000, 2005-2008) Clinical Genitourinary Cancer (Section Editor, 2002-2009) Urologic Oncology (Associate Editor, 1999-2002) Journal of Urology (Board of Consultants, 1996-2007)

Key Interests:
Dr. Kattan is interested in the development, validation, and use of prediction models.  He has developed several such models in cancer and released them as freely available software, from http://rcalc.ccf.org.   Dr. Kattan is also interested in quality of life assessment to support medical decision making, such as utility assessment.  He is also interested in decision analysis, cost-effectiveness analysis and comparative effectiveness.

Selected Publications: (Click here for complete PubMed listing)
Kattan MW.  Comparison of Cox regression with other methods for determining prediction models and nomograms.  J Urol 2003; 170: S6-S10.

Kattan MW.  Comparing treatment outcomes using utility assessment for health-related quality of life.  Oncology 2003; 17(12): 1687-1693.

Kattan MW.  Evaluating a new marker’s predictive contribution.  Clin Can Res 2004; 10: 882-824.

Kattan MW, Vickers AJ.  Incorporating predictions of individual patient risk in clinical trials. Urol Oncol. 2004 Jul-Aug;22(4):348-52.

Befort CA, Zelefsky MJ, Scardino PT, Borrayo E, Giesler RB, Kattan MW.  A measure of health-related quality of life among localized prostate cancer patients: result from on-going scale development.  Clin Prostate Cancer.  2005 Sept;4(2):100-108.

Vickers AJ, Kattan MW, Sargent D.  Method for evaluating prediction models that apply the results of randomized trials to individual patients.  Trials.  2007 June 5;8(1):14.

Heller G, Kattan MW, Scher HI.  Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data.  Med Decis Making.  Med Decis Making.  2007, Jul-Aug;27(4):380-386.

Vickers AJ, Basch E, Kattan MW.  Against diagnosis.  Ann Intern Med. 2008 Aug 5;149(3):200-203.

Fu AZ, Kattan MW.  Utilities should not be multiplied: evidence from the preference-based scores in the United States.  Med Care.  2008 Sep;46(9):984-990.

Kattan MW, Gönen M.  The prediction philosophy in statistics.  Urol Oncol. 2008 May-Jun;26(3):316-319.

Kattan MW.  Comparative effectiveness:  a table of expected benefits and harms.  Med Decis Making.  2009 Nov-Dec;29(6):NP3-NP5.

Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW.  Assessing the performance of prediction models: a framework for traditional and novel measures.  Epidemiology. 2010 Jan;21(1):128-138.

Kattan MW.  Doc, What Are My Chances? A Conversation About Prognostic Uncertainty.  Eur Urol.  2010 Nov;59:224.

Kattan MW.  Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets.  Eur Urol.  2011 April;59(4):566-567.

Patents:

• Awarded:
  "A Nomogram to Aid in the Decision to Treat Clinically Localized Prostate Cancer." 1999, US Patent No: 5,993,388.
  
  "Nomograms to Aid in the Treatment of Prostatic Cancer." 2002, US Patent No: 6,409,664.
• Published:
  "Method to determine outcome for patients with prostatic disease." 2003, US Patent Application Number: 20030235816
  
  "Methods to predict death from breast cancer." 2005, US Patent Application Number: 20050019798
  
  "Methods to predict additional nodal metastases in breast cancer patients." 2005, US Patent Application Number: 20050282146
  
  "Method to predict prostate cancer." 2005, US Patent Application Number: 20050282199
  
  "Method to predict positive repeat prostate biopsy." 2007, US Patent Application Number: 20070111269
  
  "Method to predict risk of BPH progression." 2007, US Patent Application Number: 20070134725

My CV
Biographical Sketch